vs

Side-by-side financial comparison of LCI INDUSTRIES (LCII) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $932.7M, roughly 1.0× LCI INDUSTRIES). LCI INDUSTRIES runs the higher net margin — 2.0% vs -15.2%, a 17.2% gap on every dollar of revenue. On growth, LCI INDUSTRIES posted the faster year-over-year revenue change (16.1% vs 6.2%). LCI INDUSTRIES produced more free cash flow last quarter ($64.3M vs $60.0M). Over the past eight quarters, DENTSPLY SIRONA Inc.'s revenue compounded faster (0.4% CAGR vs -1.8%).

Lucky Core Industries Limited, formerly known as ICI Pakistan, is a Pakistani conglomerate company headquartered in Karachi. It manufactures polyester, pharmaceutical, agrochemical, soda ash, and veterinary medicine.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

LCII vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.0× larger
XRAY
$961.0M
$932.7M
LCII
Growing faster (revenue YoY)
LCII
LCII
+9.9% gap
LCII
16.1%
6.2%
XRAY
Higher net margin
LCII
LCII
17.2% more per $
LCII
2.0%
-15.2%
XRAY
More free cash flow
LCII
LCII
$4.3M more FCF
LCII
$64.3M
$60.0M
XRAY
Faster 2-yr revenue CAGR
XRAY
XRAY
Annualised
XRAY
0.4%
-1.8%
LCII

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LCII
LCII
XRAY
XRAY
Revenue
$932.7M
$961.0M
Net Profit
$18.7M
$-146.0M
Gross Margin
22.1%
46.1%
Operating Margin
3.8%
-14.5%
Net Margin
2.0%
-15.2%
Revenue YoY
16.1%
6.2%
Net Profit YoY
95.7%
66.0%
EPS (diluted)
$0.79
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LCII
LCII
XRAY
XRAY
Q4 25
$932.7M
$961.0M
Q3 25
$1.0B
$904.0M
Q2 25
$1.1B
$936.0M
Q1 25
$1.0B
$879.0M
Q4 24
$803.1M
$905.0M
Q3 24
$915.5M
$951.0M
Q2 24
$1.1B
$984.0M
Q1 24
$968.0M
$953.0M
Net Profit
LCII
LCII
XRAY
XRAY
Q4 25
$18.7M
$-146.0M
Q3 25
$62.5M
$-427.0M
Q2 25
$57.6M
$-45.0M
Q1 25
$49.4M
$20.0M
Q4 24
$9.5M
$-430.0M
Q3 24
$35.6M
$-494.0M
Q2 24
$61.2M
$-4.0M
Q1 24
$36.5M
$18.0M
Gross Margin
LCII
LCII
XRAY
XRAY
Q4 25
22.1%
46.1%
Q3 25
24.4%
48.8%
Q2 25
24.4%
52.4%
Q1 25
24.1%
53.0%
Q4 24
21.1%
49.3%
Q3 24
24.0%
52.1%
Q2 24
25.3%
51.9%
Q1 24
23.1%
53.1%
Operating Margin
LCII
LCII
XRAY
XRAY
Q4 25
3.8%
-14.5%
Q3 25
7.3%
-24.1%
Q2 25
7.9%
-13.7%
Q1 25
7.8%
7.2%
Q4 24
2.0%
-56.2%
Q3 24
5.9%
-48.6%
Q2 24
8.6%
5.1%
Q1 24
6.0%
4.4%
Net Margin
LCII
LCII
XRAY
XRAY
Q4 25
2.0%
-15.2%
Q3 25
6.0%
-47.2%
Q2 25
5.2%
-4.8%
Q1 25
4.7%
2.3%
Q4 24
1.2%
-47.5%
Q3 24
3.9%
-51.9%
Q2 24
5.8%
-0.4%
Q1 24
3.8%
1.9%
EPS (diluted)
LCII
LCII
XRAY
XRAY
Q4 25
$0.79
$-0.74
Q3 25
$2.55
$-2.14
Q2 25
$2.29
$-0.22
Q1 25
$1.94
$0.10
Q4 24
$0.37
$-2.09
Q3 24
$1.39
$-2.46
Q2 24
$2.40
$-0.02
Q1 24
$1.44
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LCII
LCII
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$222.6M
$326.0M
Total DebtLower is stronger
$945.2M
$2.3B
Stockholders' EquityBook value
$1.4B
$1.3B
Total Assets
$3.2B
$5.4B
Debt / EquityLower = less leverage
0.69×
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LCII
LCII
XRAY
XRAY
Q4 25
$222.6M
$326.0M
Q3 25
$199.7M
$363.0M
Q2 25
$191.9M
$359.0M
Q1 25
$231.2M
$398.0M
Q4 24
$165.8M
$272.0M
Q3 24
$161.2M
$296.0M
Q2 24
$130.4M
$279.0M
Q1 24
$22.6M
$291.0M
Total Debt
LCII
LCII
XRAY
XRAY
Q4 25
$945.2M
$2.3B
Q3 25
$947.8M
Q2 25
$948.0M
Q1 25
$938.3M
Q4 24
$757.3M
$1.7B
Q3 24
$822.5M
Q2 24
$829.7M
Q1 24
$855.3M
Stockholders' Equity
LCII
LCII
XRAY
XRAY
Q4 25
$1.4B
$1.3B
Q3 25
$1.4B
$1.5B
Q2 25
$1.4B
$2.0B
Q1 25
$1.4B
$2.0B
Q4 24
$1.4B
$1.9B
Q3 24
$1.4B
$2.5B
Q2 24
$1.4B
$3.1B
Q1 24
$1.4B
$3.3B
Total Assets
LCII
LCII
XRAY
XRAY
Q4 25
$3.2B
$5.4B
Q3 25
$3.2B
$5.7B
Q2 25
$3.2B
$6.1B
Q1 25
$3.1B
$6.0B
Q4 24
$2.9B
$5.8B
Q3 24
$3.0B
$6.6B
Q2 24
$3.0B
$6.9B
Q1 24
$3.0B
$7.1B
Debt / Equity
LCII
LCII
XRAY
XRAY
Q4 25
0.69×
1.70×
Q3 25
0.70×
Q2 25
0.68×
Q1 25
0.69×
Q4 24
0.55×
0.90×
Q3 24
0.58×
Q2 24
0.60×
Q1 24
0.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LCII
LCII
XRAY
XRAY
Operating Cash FlowLast quarter
$78.9M
$101.0M
Free Cash FlowOCF − Capex
$64.3M
$60.0M
FCF MarginFCF / Revenue
6.9%
6.2%
Capex IntensityCapex / Revenue
1.6%
4.3%
Cash ConversionOCF / Net Profit
4.22×
TTM Free Cash FlowTrailing 4 quarters
$278.3M
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LCII
LCII
XRAY
XRAY
Q4 25
$78.9M
$101.0M
Q3 25
$97.2M
$79.0M
Q2 25
$112.2M
$48.0M
Q1 25
$42.7M
$7.0M
Q4 24
$106.6M
$87.0M
Q3 24
$78.4M
$141.0M
Q2 24
$192.9M
$208.0M
Q1 24
$-7.7M
$25.0M
Free Cash Flow
LCII
LCII
XRAY
XRAY
Q4 25
$64.3M
$60.0M
Q3 25
$80.9M
$40.0M
Q2 25
$99.5M
$16.0M
Q1 25
$33.7M
$-12.0M
Q4 24
$95.7M
$36.0M
Q3 24
$68.3M
$98.0M
Q2 24
$180.2M
$156.0M
Q1 24
$-16.3M
$-9.0M
FCF Margin
LCII
LCII
XRAY
XRAY
Q4 25
6.9%
6.2%
Q3 25
7.8%
4.4%
Q2 25
9.0%
1.7%
Q1 25
3.2%
-1.4%
Q4 24
11.9%
4.0%
Q3 24
7.5%
10.3%
Q2 24
17.1%
15.9%
Q1 24
-1.7%
-0.9%
Capex Intensity
LCII
LCII
XRAY
XRAY
Q4 25
1.6%
4.3%
Q3 25
1.6%
4.3%
Q2 25
1.2%
3.4%
Q1 25
0.9%
2.2%
Q4 24
1.4%
5.6%
Q3 24
1.1%
4.5%
Q2 24
1.2%
5.3%
Q1 24
0.9%
3.6%
Cash Conversion
LCII
LCII
XRAY
XRAY
Q4 25
4.22×
Q3 25
1.55×
Q2 25
1.95×
Q1 25
0.86×
0.35×
Q4 24
11.17×
Q3 24
2.20×
Q2 24
3.15×
Q1 24
-0.21×
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LCII
LCII

Travel Trailer And Fifth Wheels$378.4M41%
Chassis Chassis Partsand Slideout Mechanisms$206.1M22%
Furnitureand Mattresses$120.4M13%
Appliances$69.9M7%
Other Products$69.1M7%
Axlesand Suspension Solutions$62.3M7%
Motorhomes$34.2M4%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons